Yun CO - Search Results

1

A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.

Hu Z, Robbins JS, Pister A, Zafar MB, Zhang ZW, Gupta J, Lee KJ, Newman K, Yun CO, Guise T, Seth P. Hu Z, et al. Among authors: yun co. Cancer Gene Ther. 2010 Apr;17(4):235-43. doi: 10.1038/cgt.2009.72. Epub 2009 Oct 2. Cancer Gene Ther. 2010. PMID: 19798122 Free PMC article.

2

S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma.

Lee K, Yun ST, Yun CO, Ahn BY, Jo EC. Lee K, et al. Among authors: yun st, yun co. Gene Ther. 2012 Oct;19(10):967-77. doi: 10.1038/gt.2011.168. Epub 2011 Oct 27. Gene Ther. 2012. PMID: 22033466

3

Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.

Choi JW, Kang E, Kwon OJ, Yun TJ, Park HK, Kim PH, Kim SW, Kim JH, Yun CO. Choi JW, et al. Among authors: yun co, yun tj. Gene Ther. 2013 Sep;20(9):880-92. doi: 10.1038/gt.2013.10. Epub 2013 Mar 21. Gene Ther. 2013. PMID: 23514707

4

Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα.

Choi IK, Lee JS, Zhang SN, Park J, Sonn CH, Lee KM, Yun CO. Choi IK, et al. Among authors: yun co. Gene Ther. 2011 Sep;18(9):898-909. doi: 10.1038/gt.2011.37. Epub 2011 Mar 31. Gene Ther. 2011. PMID: 21451575 Free PMC article.

5

Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.

Yoo JY, Kim JH, Kim J, Huang JH, Zhang SN, Kang YA, Kim H, Yun CO. Yoo JY, et al. Among authors: yun co. Gene Ther. 2008 May;15(9):635-51. doi: 10.1038/gt.2008.3. Epub 2008 Feb 14. Gene Ther. 2008. PMID: 18273054

6

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO. Choi KJ, et al. Among authors: yun co. Gene Ther. 2006 Jul;13(13):1010-20. doi: 10.1038/sj.gt.3302759. Epub 2006 Mar 9. Gene Ther. 2006. PMID: 16525479

7

Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.

Choi IK, Yun CO. Choi IK, et al. Among authors: yun co. Cancer Gene Ther. 2013 Feb;20(2):70-6. doi: 10.1038/cgt.2012.95. Epub 2013 Jan 11. Cancer Gene Ther. 2013. PMID: 23306610 Review.

8

A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy.

Park J, Singha K, Son S, Kim J, Namgung R, Yun CO, Kim WJ. Park J, et al. Among authors: yun co. Cancer Gene Ther. 2012 Nov;19(11):741-8. doi: 10.1038/cgt.2012.64. Epub 2012 Sep 28. Cancer Gene Ther. 2012. PMID: 23018622 Review.

9

Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy.

Choi IK, Lee YS, Yoo JY, Yoon AR, Kim H, Kim DS, Seidler DG, Kim JH, Yun CO. Choi IK, et al. Among authors: yun co. Gene Ther. 2010 Feb;17(2):190-201. doi: 10.1038/gt.2009.142. Epub 2009 Nov 12. Gene Ther. 2010. PMID: 19907500

10

Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect.

Kim J, Kim PH, Yoo JY, Yoon AR, Choi HJ, Seong J, Kim IW, Kim JH, Yun CO. Kim J, et al. Among authors: yun co. Gene Ther. 2009 Sep;16(9):1111-21. doi: 10.1038/gt.2009.72. Epub 2009 Jun 4. Gene Ther. 2009. PMID: 19494843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters